Gilchuk, Pavlo
Bombardi, Robin G.
Erasmus, Jesse H.
Tan, Qing
Nargi, Rachel
Soto, Cinque
Abbink, Peter http://orcid.org/0000-0003-1978-088X
Suscovich, Todd J. http://orcid.org/0000-0002-9811-9792
Durnell, Lorellin A.
Khandhar, Amit
Archer, Jacob
Liang, Jenny
Fouch, Mallorie E.
Davidson, Edgar
Doranz, Benjamin J. http://orcid.org/0000-0002-8245-3083
Jones, Taylor
Larson, Elise
Ertel, Stacey
Granger, Brian
Fuerte-Stone, Jasmine
Roy, Vicky
Broge, Thomas
Linnekin, Thomas C.
Linde, Caitlyn H.
Gorman, Matthew J.
Nkolola, Joseph
Alter, Galit http://orcid.org/0000-0002-7680-9215
Reed, Steven G.
Barouch, Dan H.
Diamond, Michael S. http://orcid.org/0000-0002-8791-3165
Crowe, James E. Jr http://orcid.org/0000-0002-0049-1079
Van Hoeven, Neal http://orcid.org/0000-0002-1636-4824
Thackray, Larissa B. http://orcid.org/0000-0002-9380-6569
Carnahan, Robert H. http://orcid.org/0000-0001-5230-1532
Funding for this research was provided by:
United States Department of Defense | Defense Advanced Research Projects Agency (HR0011-18-2-0001, HR0011-18-2-0001, HR0011-18-2-0001, HR0011-18-2-0001, HR0011-18-2-0001, HR0011-18-2-0001, HR0011-18-2-0001, HR0011-18-2-0001, HR0011-18-2-0001, HR0011-18-2-0001, HR0011-18-2-0001, HR0011-18-2-0001, HR0011-18-2-0001, HR0011-18-2-0001, HR0011-18-2-0001, HR0011-18-2-0001, HR0011-18-2-0001, HR0011-18-2-0001, HR0011-18-2-0001, HR0011-18-2-0001, HR0011-18-2-0001, HR0011-18-2-0001, HR0011-18-2-0001, HR0011-18-2-0001, HR0011-18-2-0001, HR0011-18-2-0001, HR0011-18-2-0001)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201400058C, HHSN272201400058C)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (HHSN272201400058C, HHSN272201400058C, HHSN272201400058C, HHSN272201400058C)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Article History
Received: 9 March 2020
Accepted: 26 June 2020
First Online: 3 August 2020
Competing interests
: J.L., E.D., M.E.F. and B.J.D. are employees of Integral Molecular. B.J.D. is a shareholder of Integral Molecular. G.A. has a financial interest in SeromYx, a company developing technology that describes the antibody immune response. G.A. interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies. M.S.D. is a consultant for Inbios and Emergent BioSolutions and on the Scientific Advisory Board of Moderna. J.E.C. has served as a consultant for Sanofi and is on the Scientific Advisory Boards of CompuVax and Meissa Vaccines, is a recipient of previous unrelated research grants from Moderna and Sanofi and is the founder of IDBiologics. J.H.E., A.K. and N.V.H. are listed as inventors on a patent application describing the NLC formulation. Vanderbilt University has applied for a patent (US Provisional Patent no. 62/937,603) concerning ZIKV antibodies that is related to this research. The other authors declare no competing interests.
Free to read: This content has been made available to all.